Therapeutic Pipeline

Our current programs in development for neurodegenerative diseases.

Program Target Discovery Preclinical Phase 1
EB-101 Synapse Repair -
EB-202 Synapse Repair - -

EngramBio

A science-driven biotech startup developing therapeutics to treat and reverse neurodegenerative diseases, integrating experimental biology with modern computational tools.

Location

Moraga, CA


© 2026 EngramBio. All rights reserved.